Mereo BioPharma Group plc (FRA:MAH0)
Germany · Delayed Price · Currency is EUR 0.3020
-0.0130 (-4.13%)
At close: Jan 9, 2026
Mereo BioPharma Group Market Cap
Mereo BioPharma Group has a market cap or net worth of €67.64 million as of January 9, 2026. Its market cap has decreased by -86.61% in one year.
Market Cap
67.64M
Enterprise Value
26.11M
Revenue
426.15K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.30
Market Cap Chart
Since April 24, 2019, Mereo BioPharma Group's market cap has decreased from 111.54M to 67.64M, a decrease of -39.36%. That is a compound annual growth rate of -7.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 67.64M | 19.76% |
| Dec 31, 2025 | 56.48M | -89.21% |
| Dec 31, 2024 | 523.66M | 78.98% |
| Dec 29, 2023 | 292.57M | 257.14% |
| Dec 30, 2022 | 81.92M | -46.41% |
| Dec 31, 2021 | 152.86M | -22.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |